{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T18:01:01Z","timestamp":1775671261906,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,24]]},"DOI":"10.7759\/cureus.95339","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T17:10:43Z","timestamp":1761325843000},"source":"Crossref","is-referenced-by-count":1,"title":["Short- and Long-Term Outcomes of Neoadjuvant Chemotherapy in Operable Locally Advanced Colon Cancer: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Adil Mohamed Ali","family":"Hassan Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammar","family":"Elnour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Aljenaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma Bakri","family":"Hassan Mahmuod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hager Elsir","family":"Sherfeldin Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami Mohammed","family":"Elhassan Elsafi Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saba","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musab","family":"Mukhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101174","article-title":"Global colorectal cancer burden in 2020 and projections to 2040","volume":"14","author":"Xi Y","year":"2021","unstructured":"Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021, 14:101174. 10.1016\/j.tranon.2021.101174","journal-title":"Transl Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.14740\/gr1239","article-title":"Colon cancer: a clinician\u2019s perspective in 2019","volume":"13","author":"Ahmed M","year":"2020","unstructured":"Ahmed M.  Colon cancer: a clinician\u2019s perspective in 2019. Gastroenterology Res. 2020, 13:1-10. 10.14740\/gr1239","journal-title":"Gastroenterology Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.22543\/2392-7674.1388","article-title":"Diagnosis and management of colon cancer patients presenting in advanced stages of complications","volume":"10","author":"Constantin VD","year":"2023","unstructured":"Constantin VD, Silaghi A, Epistatu D, Dumitriu AS, Paunica S, B\u0103lan DG, Socea B. Diagnosis and management of colon cancer patients presenting in advanced stages of complications. J Mind Med Sci. 2023, 10:51-65. 10.22543\/2392-7674.1388","journal-title":"J Mind Med Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10151-020-02289-4","article-title":"Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review","volume":"24","author":"Arredondo J","year":"2020","unstructured":"Arredondo J, Pastor E, Sim\u00f3 V, et al.. Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review. Tech Coloproctol. 2020, 24:1001-15. 10.1007\/s10151-020-02289-4","journal-title":"Tech Coloproctol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1024345","article-title":"The role of neoadjuvant chemotherapy in patients with locally advanced colon cancer: a systematic review and meta-analysis","volume":"12","author":"Liang Z","year":"2022","unstructured":"Liang Z, Li Z, Yang Q, et al.. The role of neoadjuvant chemotherapy in patients with locally advanced colon cancer: a systematic review and meta-analysis. Front Oncol. 2022, 12:1024345. 10.3389\/fonc.2022.1024345","journal-title":"Front Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0275-y","article-title":"The multidisciplinary management of rectal cancer","volume":"17","author":"Keller DS","year":"2020","unstructured":"Keller DS, Berho M, Perez RO, Wexner SD, Chand M. The multidisciplinary management of rectal cancer. Nat Rev Gastroenterol Hepatol. 2020, 17:414-29. 10.1038\/s41575-020-0275-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-021-03945-3","article-title":"Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review and meta-analysis","volume":"36","author":"Gosavi R","year":"2021","unstructured":"Gosavi R, Chia C, Michael M, Heriot AG, Warrier SK, Kong JC. Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review and meta-analysis. Int J Colorectal Dis. 2021, 36:2063-70. 10.1007\/s00384-021-03945-3","journal-title":"Int J Colorectal Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne JA","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al.. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016, 355:i4919. 10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.4_suppl.201","article-title":"Neoadjuvant chemotherapy with FOLFOXIRI for high-risk relapsed locally advanced colon cancer: a single-arm phase II trial","volume":"43","author":"Zhou Y","year":"2025","unstructured":"Zhou Y, Meng W, Qiu M. Neoadjuvant chemotherapy with FOLFOXIRI for high-risk relapsed locally advanced colon cancer: a single-arm phase II trial. Am Soc Clin Oncol. 2025, 43:201. 10.1200\/JCO.2025.43.4_suppl.201","journal-title":"Am Soc Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.4_suppl.144","article-title":"Neoadjuvant therapy in T3 and T4 colon cancer: is there a promising future?","volume":"43","author":"Pena P","year":"2025","unstructured":"Pena P, Sousa A, AlMasad Q, Kwon S, Williams R. Neoadjuvant therapy in T3 and T4 colon cancer: is there a promising future?. Am Soc Clin Oncol. 2025, 43:144. 10.1200\/JCO.2025.43.4_suppl.144","journal-title":"Am Soc Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.12.013","article-title":"Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population","volume":"36","author":"Seligmann JF","year":"2025","unstructured":"Seligmann JF, Morton D, Elliott F, et al.. Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population. Ann Oncol. 2025, 36:520-8. 10.1016\/j.annonc.2024.12.013","journal-title":"Ann Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303269","article-title":"Preoperative treatment of locally advanced rectal cancer","volume":"389","author":"Schrag D","year":"2023","unstructured":"Schrag D, Shi Q, Weiser MR, et al.. Preoperative treatment of locally advanced rectal cancer. N Engl J Med. 2023, 389:322-34. 10.1056\/NEJMoa2303269","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000005780","article-title":"Neoadjuvant chemotherapy with CAPOX versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): initial results of a phase III trial","volume":"277","author":"Mei WJ","year":"2023","unstructured":"Mei WJ, Wang XZ, Li YF, et al.. Neoadjuvant chemotherapy with CAPOX versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): initial results of a phase III trial. Ann Surg. 2023, 277:557-64. 10.1097\/SLA.0000000000005780","journal-title":"Ann Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6029","article-title":"Identification of patients with locally advanced rectal cancer eligible for neoadjuvant chemotherapy alone: results of a retrospective study","volume":"12","author":"Han YM","year":"2023","unstructured":"Han YM, Qi WX, Wang SB, Cao WG, Chen JY, Cai G. Identification of patients with locally advanced rectal cancer eligible for neoadjuvant chemotherapy alone: results of a retrospective study. Cancer Med. 2023, 12:13309-18. 10.1002\/cam4.6029","journal-title":"Cancer Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1099168","article-title":"Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy","volume":"13","author":"Yin TC","year":"2023","unstructured":"Yin TC, Chen PJ, Yeh YS, et al.. Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy. Front Oncol. 2023, 13:1099168. 10.3389\/fonc.2023.1099168","journal-title":"Front Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.953790","article-title":"Prolonged neoadjuvant chemotherapy without radiation versus total neoadjuvant therapy for locally advanced rectal cancer: a propensity score matched study","volume":"12","author":"Zhao X","year":"2022","unstructured":"Zhao X, Han P, Zhang L, et al.. Prolonged neoadjuvant chemotherapy without radiation versus total neoadjuvant therapy for locally advanced rectal cancer: a propensity score matched study. Front Oncol. 2022, 12:953790. 10.3389\/fonc.2022.953790","journal-title":"Front Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02309","article-title":"Neoadjuvant modified FOLFOX6 with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: final results of the Chinese FOWARC trial","volume":"37","author":"Deng Y","year":"2019","unstructured":"Deng Y, Chi P, Lan P, et al.. Neoadjuvant modified FOLFOX6 with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: final results of the Chinese FOWARC trial. J Clin Oncol. 2019, 37:3223-33. 10.1200\/JCO.18.02309","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2019.1835","article-title":"Comparable regional therapeutic effects between neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy for locally advanced lower rectal cancer in terms of histopathological analysis","volume":"10","author":"Sato K","year":"2019","unstructured":"Sato K, Miura T, Morohashi S, Sakamoto Y, Morohashi H, Yoshida T, Hakamada K. Comparable regional therapeutic effects between neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy for locally advanced lower rectal cancer in terms of histopathological analysis. Mol Clin Oncol. 2019, 10:619-24. 10.3892\/mco.2019.1835","journal-title":"Mol Clin Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-018-1403-9","article-title":"Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study","volume":"16","author":"Okuyama T","year":"2018","unstructured":"Okuyama T, Sameshima S, Takeshita E, et al.. Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study. World J Surg Oncol. 2018, 16:105. 10.1186\/s12957-018-1403-9","journal-title":"World J Surg Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2018.01.025","article-title":"Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer","volume":"226","author":"Sada YH","year":"2018","unstructured":"Sada YH, Tran Cao HS, Chang GJ, Artinyan A, Musher BL, Smaglo BG, Massarweh NN. Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer. J Surg Res. 2018, 226:15-23. 10.1016\/j.jss.2018.01.025","journal-title":"J Surg Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas M","year":"2010","unstructured":"Maas M, Nelemans PJ, Valentini V, et al.. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010, 11:835-44. 10.1016\/S1470-2045(10)70172-8","journal-title":"Lancet Oncol"},{"key":"ref24","article-title":"The Norton-Simon hypothesis revisited","volume":"70","author":"Norton L","year":"1986","unstructured":"Norton L, Simon R. The Norton-Simon hypothesis revisited. Cancer Treat Rep. 1986, 70:163-9.","journal-title":"Cancer Treat Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham D","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, et al.. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006, 355:11-20. 10.1056\/NEJMoa055531","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2011.05.004","article-title":"Perspectives on current tumor-node-metastasis (TNM) staging of cancers of the colon and rectum","volume":"38","author":"Hu H","year":"2011","unstructured":"Hu H, Krasinskas A, Willis J. Perspectives on current tumor-node-metastasis (TNM) staging of cancers of the colon and rectum. Semin Oncol. 2011, 38:500-10. 10.1053\/j.seminoncol.2011.05.004","journal-title":"Semin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/427237-short--and-long-term-outcomes-of-neoadjuvant-chemotherapy-in-operable-locally-advanced-colon-cancer-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T17:10:44Z","timestamp":1761325844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/427237-short--and-long-term-outcomes-of-neoadjuvant-chemotherapy-in-operable-locally-advanced-colon-cancer-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.95339","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,24]]}}}